Answers Rated A
A 25 year old smoker with a 10 pack year history
of smoking should be given what counsel to
prevent development of COPD? Which of the following medications is
*A.* Use albuterol as needed to prevent recommended as third choice in all COPD
symptoms classes?
*B.* Use ipratropium as needed to prevent *A.* Ipratropium
symptoms *B.* Theophylline
*C.* Need for an influenza vaccination *C.* Albuterol
*D.* Smoking cessation information *D.* Anoro Ellipta
*E.* All of the above - ANSWER -*D.* *E.* Roflumilast - ANSWER -*B.*
Smoking cessation information Theophylline
The risk of theophylline toxicity is *MOST* likely A patient with a prior diagnosis of COPD
to occur in a patient who has discontinued: approaches the pharmacy counter and asks for a
*A.* Smoking refund on his Combivent inhaler. The patient
*B.* Omeprazole states that he pays "a whole lotta money for a
*C.* Fluoxetine drug that doesn't work", and wants a
*D.* Warfarin replacement. He states that he knows the drug
*E.* Gentamicin - ANSWER -*A.* Smoking must be expired or old, because he has been
using this drug for 3 years now...and for 2
months, it hasn't worked like it used to. Other
JJ is a 65 yom who comes to the clinic today for than agitation, the patient is in no distress and
his annual visit. While reviewing his records you has been hospitalized once in the last year for
discover he has had 5 COPD exacerbations COPD exacerbation. Which of the following is the
requiring hospitalization since his last visit a year *MOST* appropriate course of action for this
ago. The most recent event occurred two months patient?
ago. Spirometry reveals a FEV1 of 29%. How *A.* Send the patient to the ED for further care
should you classify this patient's COPD? *B.* Ask your manager to issue a refund on the
*A.* Group A defective inhaler
*B.* Group B *C.* Review inhaler technique, and if appropriate,
*C.* Group C call his MD recognizing the progressive nature of
*D.* Group D - ANSWER -C, D (He didn't COPD and recommend the addition of a LAAC
specify the the mMRC nor the CAT...)(I'm sure *D.* Review inhaler technique, and if appropriate,
he was going for D, but not sure) cal his MD recognizing - ANSWER -*C.*
Review inhaler technique, and if appropriate, call
his MD recognizing the progressive nature of
A PDE-4 inhibitor is recommended as third COPD and recommend the addition of a LAAC
choice in which of the following COPD groups?
*A.* Group A
*B.* Group B Which of the following is/are appropriate
*C.* Group C intervention(s) for the treatment and/or
*D.* Group D - ANSWER -*C.* Group C prevention of COPD progression in a GOLD 2,
(Slide 98) Group B patient who smokes 2 packs daily?
*A.* Initiating a LABA or LAAC
1/3